Welcome Back
Click “Sign in” to agree to Cointime’s Terms of Service and acknowledge that Cointime’s Privacy Policy applies to you.
Join CoinTime
Already have an account?
Click “page.Sign up” to agree to Cointime’s <a class="underline" href="#term-of-service">Terms of Service</a> and acknowledge that Cointime’s a class="underline" href="#privacy-policy">Privacy Policy</a> applies to you.
Sign in with email
Sign up with email
Your email
Check your inbox
Click the link we sent to to sign in.
Click the link we sent to to sign up.
Adaptive Biotechnologies
company
Funding Round
Post-IPO Debt
Money Raised
$ 125M
Propotion
-
Post Valuation
-
Current Round Investors
| Investor Name | Invest Money | Lead Investor | Propotion | |
|---|---|---|---|---|
| OrbiMed | - | Yes | - | Detail |
Historical Financing
| Announced Date | Round | Money Raised | Investors | |
|---|---|---|---|---|
| Mar 24, 2022 | Post-IPO Equity | 0 | ARK Investment Management | Detail |
| Apr 15, 2014 | Series D | $ 100M | Viking Global Investors | Detail |
| Mar 5, 2018 | Secondary Market | 0 | EquityZen | Detail |
| Jul 14, 2020 | Post-IPO Equity | 0 | Detail | |
| Sep 13, 2013 | Grant | $ 2.50M | Detail | |
| May 7, 2015 | Series F | $ 195M | Matrix Capital Management,Rock Springs Capital,etc. | Detail |
| Apr 7, 2014 | Series C | $ 5M | Viking Global Investors | Detail |
| Jan 7, 2015 | Series E | $ 94M | Detail | |
| Jun 10, 2011 | Series B | $ 5.80M | Detail | |
| Mar 24, 2010 | Series A | $ 4.55M | Detail | |
| Jun 26, 2019 | IPO | $ 300M | Detail |
